AzTrials
AzTrials

Post Traumatic Stress DisorderPRANAPTSDNCT05645588

Pranayama for Posttraumatic Stress Disorder

A study testing Pranayama assisted trauma-focused standard psychotherapy (TF-SPT) and Trauma-focused standard psychotherapy (TF-SPT) in people with Post Traumatic Stress Disorder, run by Universität Duisburg-Essen.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This study aims to investigate the effect of pranayama (yoga-breathing techniques) on post-traumatic symptom severity in patients with post-traumatic stress disorder undergoing standard, out-patient, trauma-focused psychotherapy. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Post Traumatic Stress Disorder
What is being tested?
Pranayama assisted trauma-focused standard psychotherapy (TF-SPT) and Trauma-focused standard psychotherapy (TF-SPT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
No sites listed yet
Study dates
1 Jan 2025to 1 Feb 2028
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosed PTSD according to ICD-10 F43.1
  • PCL-5 Score of at least 33 points
  • Undergoing outpatient standard trauma-focused psychotherapy (Cognitive Behavioral Therapy, Psychodynamic Psychotherapy, or Systemic Psychotherapy)

Who cannot join

  • Pre-existing mental or somatic conditions that are unlikely to result in correct or safe performance of pranayama:
  • Substance dependence current use (ICD-10 F10.X, F11.X).
  • Dementia (ICD-10 F00-F03)
  • Somatoform Disorder (ICD F45.X) of moderate or severe degree according to DSM-5 300.82: ≥ 2 reactions (cognitive, emotional, or behavioral) to somatic symptoms (≥ 2 criterion-B)
  • Severe cardiovascular disease: presence of cardiac or vascular implants or grafts, e.g., pacemaker (ICD-10 Z95.X), condition after organ or tissue transplantation (ICD-10 Z94.X)
  • Acute adverse events occurring during pranayama at baseline (including neck pain, subjective sensation of pressure in the lungs, anxiety / panic)
Show all 9Show fewer
  • Cancer diagnosis in the past 5 years (ICD-10 C00-C97, D37-48)
  • Pregnancy / breastfeeding
  • Regular pranayama practice in the last 12 months

About this study

Official title: Pranayama for Outpatients With Posttraumatic Stress Disorder: a Randomized-controlled Trial

This study aims to investigate the effect of pranayama (yoga-breathing techniques) on post-traumatic symptom severity in patients with post-traumatic stress disorder undergoing standard, out-patient, trauma-focused psychotherapy. Therefore, short pranayama sessions of 5-10 minutes will be provided to the patients directly at the begin of each of psychotherapy unit, while the control group will receive standard, trauma-focused psychotherapy alone.

Being tested
Pranayama assisted trauma-focused standard psychotherapy (TF-SPT), Trauma-focused standard psychotherapy (TF-SPT)
Keywords
Posttraumatic Stress Disorder, Pranayama, Yoga, Complimentary Therapies, Somatic Symptom Disorder, SSD, PTSD, Safety, Effectiveness, Randomized Controlled Trail
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pranayama assisted trauma-focused standard psychotherapy (TF-SPT)Behavioural

    To prepare patients for the TF-SPT, they received 5-10 minutes of pranayama at the begin of each of the 10 TF-SPT units.

  • Trauma-focused standard psychotherapy (TF-SPT)Behavioural

    Patients wait for 10 TF-SPT units and then are offered to learn pranayama

Study groups in NCT05645588
Study groupRoleWhat they receive
Pranayama assisted trauma-focused standard psychotherapy (TF-SPT).ExperimentalBehavioral: Pranayama assisted trauma-focused standard psychotherapy (TF-SPT) The pranayama intervention is placed directly at the begin of the respective TF-SPT unit and will be repeated for 10 subsequent TF-SPT units.
Receives: Behavioral: Pranayama assisted trauma-focused standard psychotherapy (TF-SPT)
Trauma-focused standard psychotherapy (TF-SPT)Active comparatorBehavioral: Patients wait for 10 TF-SPT units and then are offered to learn pranayama.
Receives: Behavioral: Trauma-focused standard psychotherapy (TF-SPT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intensity of posttraumtic symptoms

    Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): The PCL-5 is a standard 20-item scale with a sum score ranging from 0 to 80 points. The cut-off point for clinically relevant symptom severity is 33 points.

    Measured: week 10

Secondary outcomes (7)
  1. Health-related quality of life

    Short Form 12 Health Survey (SF-12): The SF-12 is a standard 12-item scale with two sum scores (physical and mental quality of life) ranging from 0 to 100 points.

    Measured: week 10

  2. Anxiety

    Beck Anxiety Inventory (BAI): The BAI is a standard 21-items scale ranging from 0 to 63 points with 0-7 points = minimal anxiety, 8-15 points = mild anxiety, 16-25 points = moderate anxiety, and 26-63 points = clinically relevant anxiety.

    Measured: week 10

  3. Depression

    Beck Depression Inventory Revision (BDI-II): The BDI-II is a standard 21-items scale ranging from 0 to 63 points with 0-13 points =no/clinically not relevant depression/depression in remission, 14-19 points = mild depression, 20-28 points = moderate depression und 29-63 points = severe depression.

    Measured: week 10

  4. Breath Holding Duration

    Breath Holding Task (BHT): The BHT is standard test procedure for the measurement of ability of the suppression of the respiratory reflex.

    Measured: week 10

  5. Adverse Events

    Number of patients with adverse events and types of the adverse events

    Measured: weeks 1,2,3,4,5,6,7,8,9,10

  6. Therapist Global Improvement

    Clinician Global Impression of Improvement (CGI-I) rated by the therapist on 1 item ranging from 1 to 7.

    Measured: week 10

  7. Patient Global Improvement

    Patient Global Impression of Improvement (PGI-I) rated by the patient on 1 item ranging from 1 to 7.

    Measured: week 10

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2022
  2. Study start1 Jan 2025 (estimated)
  3. Primary completion1 Feb 2027 (estimated)
  4. Study completion1 Feb 2028 (estimated)

Why it stopped: no sufficient funding, employee have left the company

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05645588
Sponsor's protocol ID
22-10859-BO
Acronym
PRANAPTSD
Status last verified
Mar 2025
First submitted
1 Dec 2022
Last updated
30 Mar 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Pranayama assisted trauma-focused standard psychotherapy (TF-SPT) and Trauma-focused standard psychotherapy (TF-SPT) in people with Post Traumatic Stress Disorder, run by Universität Duisburg-Essen.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 30 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intensity of posttraumtic symptoms (time frame: week 10). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in